|
"ann lii cheng"的相关文件
显示项目 621-630 / 690 (共69页)
<< < 58 59 60 61 62 63 64 65 66 67 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2018-09-10T08:15:22Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Shao, Y.-Y. and Kuo, K.-T. and Hu, F.-C. and Lu, Y.-S. and Huang, C.-S. and Liau, J.-Y. and Lee, W.-C. and Hsu, C. and Kuo, W.-H. and Chang, K.-J. and Lin, C.-H. and Cheng, A.-L.; CHIUN-SHENG HUANG; Yu-Yun Shao; JAU-YU LIAU; CHING-HUNG LIN; KUAN-TING KUO; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:13:48Z |
Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma
|
Omata, M.;Lesmana, L.A.;Tateishi, R.;Chen, P.-J.;Lin, S.-M.;Yoshida, H.;Kudo, M.;Lee, J.M.;Choi, B.I.;Poon, R.T.P.;Shiina, S.;Cheng, A.L.;Jia, J.-D.;Obi, S.;Han, K.H.;Jafri, W.;Chow, P.;Lim, S.G.;Chawla, Y.K.;Budihusodo, U.;Gani, R.A.;Lesmana, C.R.;Putranto, T.A.;Liaw, Y.F.;Sarin, S.K.; PEI-JER CHEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:13:43Z |
Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation
|
Chen, K.-F.;Yu, H.-C.;Liu, T.-H.;Lee, S.-S.;Chen, P.-J.;Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG; SHOEI-SHENG LEE |
| 臺大學術典藏 |
2018-09-10T08:06:38Z |
Unusual presentation of multiple pathologic bone fractures in a patient with gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo, S.-H. and Yen, R.-F. and Lin, C.-W. and Chen, L.-T. and Tien, H.F. and Cheng, A.-L.; HWEI-FANG TIEN; Sung-Hsin Kuo; RUOH-FANG YEN; CHUNG-WU LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:06:37Z |
Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells
|
Weng, Y.-I.;Hsu, P.-Y.;Liyanarachchi, S.;Liu, J.;Deatherage, D.E.;Huang, Y.-W.;Zuo, T.;Rodriguez, B.;Lin, C.-H.;Cheng, A.-L.;Huang, T.H.-M.; CHING-HUNG LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:06:36Z |
O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers
|
Wu, Pei-Fang;Kuo, Kuan-Ting;Kuo, Lu-Ting;Lin, Yi-Ting;Lee, Wei-Chung;Lu, Yen-Shen;Yang, Chih-Hsin;Wu, Ruey-Meei;Tu, Yong-Kwang;Tasi, Jui-Chang;Tseng, Ham-Min;Tseng, Sheng-Hong;Cheng, Ann-Lii;Lin, Ching-Hung; Wu, Pei-Fang; Ruey-Meei Wu; Lu-Ting Kuo; Kuo, Kuan-Ting; Kuo, Lu-Ting; Yong-Kwang Tu; Lin, Yi-Ting; CHING-HUNG LIN; KUAN-TING KUO; Lee, Wei-Chung; ANN-LII CHENG; Lu, Yen-Shen; Yang, Chih-Hsin; Wu, Ruey-Meei; Tu, Yong-Kwang; Tasi, Jui-Chang; Tseng, Ham-Min; Tseng, Sheng-Hong; Cheng, Ann-Lii; Lin, Ching-Hung |
| 臺大學術典藏 |
2018-09-10T08:04:03Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
HSIANG-PO HUANG; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:03:10Z |
Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC
|
Lin, Z.-Z. and Jeng, Y.-M. and Hu, F.-C. and Pan, H.-W. and Tsao, H.-W. and Lai, P. and Lee, P. and Cheng, A.-L. and Hsu, H.-C.; PO-HUANG LEE; YUNG-MING JENG; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:37:25Z |
Synergistic Effect of Radiation and Interleukin-6 on Hepatitis B Virus Reactivation in Liver Through STAT3 Signaling Pathway
|
Chou, C.H. and Chen, P.-J. and Jeng, Y.-M. and Cheng, A.-L. and Huang, L.-R. and Cheng, J.C.-H.; YUNG-MING JENG; PEI-JER CHEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:26:16Z |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer
|
Ch'ang, H.-J. and Huang, C.-L. and Wang, H.-P. and Shiah, H.-S. and Chang, M.-C. and Jan, C.-M. and Chen, J.-S. and Tien, Y.-W. and Hwang, T.-L. and Lin, J.-T. and Cheng, A.-L. and Whang-Peng, J. and Chen, L.-T.; YU-WEN TIEN; ANN-LII CHENG |
显示项目 621-630 / 690 (共69页)
<< < 58 59 60 61 62 63 64 65 66 67 > >>
每页显示[10|25|50]项目
|
